Skip to main content
. 2015 Jun 1;8(6):6560–6565.

Figure 5.

Figure 5

Kaplan-Meier survival analysis by LRP16 status (n = 90). The y-axis represents the percentage of patients; the x-axis, their survival in months. The green line represents LRP16-positive patients with a trend of worse survival than the blue line representing LRP16-negative patients (Log rank = 25.799; P = 0.0001. Overall median survival (OS) time was 20.0 months for the LRP16- positive group and 42.0 months for the LRP16-negative group.